Bottom Line: PD-L2 protein expression in human tumors was associated with clinical response to pembrolizumab (Keytruda), an anti-PD-1 immunotherapy, independent of PD-L1 expression, in patients...
Credit: Photo Credit: Andrew Neary, NYU Langone By acting out scenarios commonly seen in the clinic, real-life transgender actors can help residents learn to provide...
Cells in nearly any part of the body can become cancerous and transform into tumors. Some, like skin cancer, are relatively accessible to treatment via...
Portland, Ore., June 15, 2017 - An initiative led by the Veterans Health Administration (VHA) reduced Methicillin-resistant Staphylococcus aureus (MRSA) infections by 89 percent over...
Credit: Courtesy of A. Baranski, M. Schäfer, U. Bauder-Wüst, M. Roscher, J. Schmidt, E. Stenau, L. Maier-Hein, M. Eder, K. Kopka, German Cancer Research Center,...
Credit: Stanford University DENVER, Colo. - Simultaneous injections of the radiopharmaceuticals fluorine-18 fluorodeoxyglucose (18F-FDG) and 18F-sodium fluoride (18F-NaF) followed by quantitative s..
TAMPA, Fla. (June 14, 2017) - A collaboration between Saïd M. Sebti, Ph.D., chair of Moffitt Cancer Center's Drug Discovery Department, and Michele Pagano, M.D.,...
